Uptake of cisplatin and its metabolites into rat and rabbit renal cortical slices

Pharmacy and Pharmacology Communications

Volumn 4, Issue 9, 1998, Pages 455-458

  Harada, Yukie ^a   Kumagai, Eiko ^a   Nagai, Naomi ^a   Hanada, Kazuhiko ^a   Ogata, Hiroyasu ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; CIMETIDINE; CISPLATIN; DRUG METABOLITE; GLUTATHIONE; QUINIDINE; THIOSULFATE; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; KIDNEY CORTEX SLICE; MALE; NONHUMAN; RABBIT; RAT;

EID: 0031706001     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. +)-ATPase by membrane lipids: difference between species. Biochim. Biophys. Acta. 729: 75-84
2. +-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum (II) in human ovarian carcinoma cells. Cancer Res. 51: 3677-3681
3. Cross, R. J., Taggart, J. V. (1950) Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. Am. J. Physiol. 161: 181-190
4. Hanada, K., Nagai, N., Ogata, H. (1995) Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography. J. Chromatogr. B 663: 181-186
5. Ishikawa, T., Ali-Osman, F. (1993) Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. J. Biol. Chem. 268: 20116-20125
6. Jacobs, C., Kaubisch, S., Halsey, J., Lum, B. L., Gosland, M., Coleman, N., Sikic, B. I. (1991) The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 67: 1518-1524
7. Klein, J., Bentur, Y., Cheung. D., Moselhy, G., Koren, G. (1991) Renal handling of cisplatin (interactions with organic anions and cations in the dogs). Clin. Invest. Med. 14: 388-394
8. Nagai, N., Ogata, H. (1997) Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats - importance of area under the concentration-time curve (AUC) as the major toxicodynamic determination in vivo. Cancer Chemother. Pharmacol. 40: 11-18
9. Nagai, N., Hotta, K., Yamamura, M., Ogata, H. (1995) Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity. Cancer Chemother. Pharmacol. 36: 404-412
10. Nagai, N., Okuda, R., Kinoshita, M., Ogata, H. (1996) Decomposition kinetics of cisplatin in human biological fluids. J. Pharm. Pharmacol. 48: 918-924
11. Nelson, J. A., Santos, G., Herbert, B. H. (1984) Mechanisms for the renal secretion of cisplatin. Cancer Treat. Rep. 68: 849-853
12. Rossof, A. H., Slayton, R. E., Perlia, C. P. (1972) Preliminary clinical experience with cis-diamminedichloroplatinum (II). Cancer 30: 1451-1456
13. Safirstein, R., Miller, P., Guttenplan, J. B. (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int. 25: 753-758
14. Segai, E., Le Pecq, J. B. (1985) Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum (II) with its targets. Cancer Res. 45: 492-498
15. Sokol, P. P., McKinney, T. D. (1990) Mechanism of organic cation transport in rabbit renal baselateral membrane vesicles. Am. J. Physiol. 258: F1599-F1607
16. Sokol, P. P., Huiatt, K. R., Holoman, P. D., Ross, C. R. (1989) Gentamicin and verapamil compete for a common transport mechanism in renal brush border membrane vesicles. J. Pharmacol. Exp. Ther. 251: 937-942
17. Takano, M., Inui, K., Okano, T., Saito, H., Hori, R. (1984) Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border membrane vesicles. Biochim. Biophys. Acta. 773: 113-124
18. White, R. P., Samson, F. E. (1954) Determination of inulin in plasma and urine by use of anthrone. J. Lab. Clin. Med. 43: 475-478